4//SEC Filing
Oxtoby Andrew 4
Accession 0000899243-20-025349
CIK 0001631650other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:19 PM ET
Size
5.7 KB
Accession
0000899243-20-025349
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2020-09-15$34.25/sh−840$28,770→ 26,595 total
Footnotes (3)
- [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award
- [F2]Includes 11,250 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date
- [F3]Includes 9,000 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from January 19, 2019 subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:19 PM ET
- Size
- 5.7 KB